HCA vs REGN — Key Metrics

Metric HCA (HCA HEALTHCARE INC) REGN (REGENERON PHARMACEUTICALS INC)
Price476.35945.53
Market Cap99.51 Billion97.81 Billion
P/E (TTM)15.620.11
P/B (Quarterly)-12.3642.865
P/S (TTM)1.265.79
Net Profit Margin (TTM)8.628.5
Gross Margin (TTM)42.885.8
ROE (TTM)-100.215.1
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

HCA HEALTHCARE INC
vs
 
REGENERON PHARMACEUTICALS INC
 
HCA HEALTHCARE INC
vs
 
REGENERON PHARMACEUTICALS INC
Performance Comparison
AI Model Recommendation
HCA · HCA HEALTHCARE INC

Outperform

4
UnderperformOutperform
REGN · REGENERON PHARMACEUTICALS INC

Outperform

60
UnderperformOutperform
Recommendation Summary

Both stocks are projected to outperform the market over the next year. If you have to make a choice, Upfront Recommendation: REGN.

Financial Metrics
Prices delayed ~15 min
HCA Metrics REGN
$476.35 Price $945.53
— Market Capitalization —
15.6 Price to Earnings Ratio 20.11
1.26 Price to Sales 5.79
16.66 Price to FCF Ratio 25.56
2.96 Price to Gross Profit 6.75
6.14 Price to Current Assets 4.7

HCA vs REGN at a glance

HCA Healthcare INC (HCA) and Regeneron Pharmaceuticals INC (REGN) are both in the Healthcare sector. They are similar in size: $99.5 billion and $97.8 billion in market value.

On trailing-twelve-month figures, HCA trades at 15.6 times trailing earnings and REGN at 20.1; net profit margins are 8.6% and 28.5%.

The Upfront Investment model currently rates both Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.